Related Experiment Videos
Altered thalamic membrane phospholipids in schizophrenia: a postmortem study
Andrea Schmitt1, Katrin Wilczek, Kaj Blennow
1Department of Psychiatry, Central Institute of Mental Health, Mannheim, Germany.
Biological Psychiatry
|June 29, 2004
Summary
Schizophrenia is linked to altered brain membrane lipids, with decreased phosphatidylcholine and increased phosphatidylserine observed in the thalamus. This suggests impaired myelination and oligodendrocyte function in patients with schizophrenia.
Area of Science:
- Neuroscience
- Biochemistry
- Psychiatry
Background:
- Membrane lipids are crucial for neuronal function.
- The thalamus's role in schizophrenia pathophysiology is understudied regarding lipid composition.
- This study investigates membrane lipid alterations in the schizophrenic thalamus.
Purpose of the Study:
- To measure and compare membrane lipid components in the thalamus of schizophrenic patients and healthy controls.
- To investigate the relationship between lipid levels and schizophrenia.
- To explore potential indicators of oligodendrocyte dysfunction and myelination deficits.
Main Methods:
- Postmortem study involving 18 schizophrenic patients and 23 healthy controls.
- Lipid extraction and thin-layer chromatography used to analyze thalamus homogenate.
- Quantification of membrane phospholipids, galactocerebrosides, and sulfatides.
Main Results:
- Decreased levels of phosphatidylcholine, sphingomyelin, and galactocerebrosides in schizophrenic patients.
- Increased phosphatidylserine levels observed in the schizophrenic group.
- No significant differences in other measured phospholipids or sulfatides; no correlation with postmortem interval or medication.
Conclusions:
- Findings support a role for altered membrane lipid metabolism in schizophrenia.
- Results indicate increased phospholipid breakdown, suggesting decreased myelination and oligodendrocyte dysfunction.
- The study's findings align with previous neuroimaging, postmortem, and gene expression research.